How to Get AndroGel in Louisiana

What Exactly Is AndroGel and Why Do Louisiana Men Use It?

AndroGel is a topical testosterone gel approved by the FDA for adult males with hypogonadism, a condition characterized by clinically and biochemically confirmed low testosterone. AbbVie markets two concentrations: the original 1% gel and the higher-concentration 1.62% formulation, with the 1.62% version now the most widely prescribed. Each pump actuation of the 1.62% product delivers 20.25 mg of testosterone; the standard starting dose is two actuations (40.5 mg) applied once daily to the upper arms or shoulders. FDA labeling permits dose titration from 20.25 mg up to 81 mg based on serum testosterone response.

Hypogonadism affects an estimated 2.1 to 3.8 million American men, and prevalence rises sharply after age 45. Symptoms include fatigue, reduced libido, depressed mood, loss of lean mass, and impaired sexual function. The T-Trials, a coordinated set of seven double-blind placebo-controlled studies (N=790 men aged 65 or older), found that testosterone treatment produced statistically significant improvements in sexual function, walking distance, and bone density versus placebo over 12 months (Snyder et al., NEJM 2016, PMID 26886521). Those findings underpin contemporary prescribing for symptomatic hypogonadism.

Louisiana has a large rural population, and many men outside Baton Rouge, New Orleans, or Shreveport lack easy access to a urologist or endocrinologist. Telehealth fills that gap. State law now permits testosterone prescribing via synchronous video or phone encounters, provided the prescriber holds an active Louisiana license and a valid prescriber-patient relationship is established.

Who Can Legally Prescribe AndroGel in Louisiana?

Any Louisiana-licensed MD, DO, nurse practitioner (NP), or physician assistant (PA) may prescribe AndroGel, subject to their individual scope of practice.

Louisiana NPs operate under a collaborative practice agreement with a supervising physician when prescribing Schedule III controlled substances, which includes testosterone. PAs must have a supervision agreement on file with the Louisiana State Board of Medical Examiners. In practical terms, this means telehealth platforms staffed by NPs or PAs can still legally prescribe testosterone gel in Louisiana, as long as the required physician oversight structure exists on the platform's side. Patients do not need to see the supervising physician directly.

A board-certified urologist or endocrinologist is not required. Primary care physicians and telehealth general practitioners write the majority of testosterone prescriptions nationally. The American Urological Association's 2018 guideline on testosterone deficiency states that "the diagnosis of TD should be made only in men with consistent symptoms and signs and unequivocally low serum testosterone levels," and does not restrict prescribing authority to specialists.

Required Labs Before an AndroGel Prescription in Louisiana

A minimum of two fasting morning total testosterone measurements on separate days is needed to confirm hypogonadism before any prescriber can write an AndroGel Rx.

The Endocrine Society's 2018 clinical practice guideline (Bhasin et al.) defines biochemical hypogonadism as a total testosterone below 300 ng/dL confirmed on two separate morning samples. Most Louisiana commercial insurers and Medicaid also require this two-sample standard for prior authorization. Beyond testosterone itself, a standard pre-treatment panel includes:

• Total testosterone (two fasting morning draws, ideally 1 to 2 weeks apart)
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Hematocrit or complete blood count (baseline before therapy that raises red cell mass)
• PSA (for men 40 and older, per FDA label guidance)
• Comprehensive metabolic panel (liver function baseline)

Some telehealth platforms operating in Louisiana will order labs directly through national reference labs such as Labcorp or Quest, with dozens of draw sites across the state. A patient in Natchitoches or Lake Charles can have blood drawn locally and results forwarded digitally to the prescribing clinician within 24 to 48 hours, keeping the total time from consult to prescription under one week in most cases.

Testosterone is best measured between 7 and 10 a.m., when diurnal peak levels occur. A mid-afternoon draw may read 15 to 25% lower than a morning sample in the same individual, which could produce a false-low result.

How the Telehealth Prescribing Process Works in Louisiana

Louisiana permits telehealth prescribing of Schedule III substances, including testosterone, via synchronous audio-video encounters. The state adopted permanent telehealth flexibilities following the COVID-19 public health emergency.

The typical sequence through a telehealth TRT platform operating in Louisiana looks like this:

1. Online intake form (symptoms, medical history, current medications). Usually 10 to 15 minutes.
2. Lab order or upload. The platform orders labs or accepts recent results (within 6 months for most providers).
3. Synchronous video visit with a licensed Louisiana provider. Average consult is 20 to 30 minutes.
4. Prescription sent to the patient's chosen Louisiana pharmacy, or to a compounding 503A pharmacy with shipping capability.
5. Follow-up labs at 6 to 8 weeks to confirm testosterone levels are in the mid-normal range (450 to 700 ng/dL is a common target) and that hematocrit has not exceeded 54%.

HealthRX's internal clinical protocol recommends that all Louisiana patients starting AndroGel or compounded testosterone gel receive a repeat hematocrit at 3 months, not just 6 to 8 weeks, because polycythemia risk in men over 55 peaks in the first 90 days of therapy. This 3-month checkpoint is not explicitly required by the FDA label but aligns with the Endocrine Society's guidance to monitor every 3 to 6 months during the first year.

Brand AndroGel vs. 503A-Compounded Testosterone Gel in Louisiana

Both options are legally available to Louisiana patients, and the choice often comes down to insurance coverage and cost.

Brand AndroGel (AbbVie): The FDA-approved product with documented bioavailability and strict manufacturing standards. Retail cost without insurance is approximately $350 to $500 per month for the 1.62% formulation. With a GoodRx coupon, that figure drops to roughly $180 to $240 at major Louisiana chains including Walgreens, CVS, and Walmart pharmacies.

503A-compounded testosterone gel: Louisiana's Board of Pharmacy licenses 503A compounding pharmacies, which prepare patient-specific formulations under a valid prescription. A compounded 1% or 2% testosterone gel typically costs $40 to $90 per month, making it a common choice for uninsured or underinsured patients. The FDA does not review compounded formulations for safety or efficacy in the same way it reviews brand drugs, so patients should confirm the pharmacy holds current Louisiana licensure and follows USP Chapter 795 standards.

Louisiana Medicaid does not cover AndroGel for male hypogonadism. Most commercial plans in Louisiana (Blue Cross Blue Shield of Louisiana, Humana, Aetna, United) require prior authorization and typically cover the brand product only after step therapy with a lower-cost generic testosterone product has been attempted or documented as inappropriate.

Navigating Prior Authorization for AndroGel in Louisiana

Prior authorization (PA) is the single biggest friction point for Louisiana patients seeking brand AndroGel through insurance.

A standard PA request for AndroGel in Louisiana generally requires:

• Two documented serum total testosterone values below 300 ng/dL, drawn on separate days before 10 a.m.
• Documentation of at least two qualifying symptoms (erectile dysfunction, decreased libido, fatigue, loss of lean body mass, depressed mood)
• Confirmation that the diagnosis is primary or secondary hypogonadism, not age-related decline alone
• For some plans, evidence that a generic testosterone gel or solution was trialed first, or a clinician attestation that it is contraindicated

Blue Cross Blue Shield of Louisiana's medical policy, as of 2024, additionally requires that LH and FSH values be included in the PA packet to rule out reversible secondary causes. Missing this single lab is a leading reason for first-round PA denials in Louisiana. Ensure your prescribing clinician includes LH/FSH results even when the insurance criteria sheet does not explicitly list them.

PA approval turnaround through Louisiana commercial insurers averages 3 to 7 business days for standard review and 24 to 72 hours for urgent review. Appeals are available if denied, and a peer-to-peer call between your physician and the insurer's medical director resolves a significant share of initial denials.

Transferring an Existing AndroGel Prescription to Louisiana

If you already have a valid AndroGel prescription from another state and are relocating to Louisiana, transfer is straightforward for retail pharmacy fills but requires a new prescriber relationship for ongoing refills.

Federal law and Louisiana pharmacy rules allow a pharmacist to transfer a Schedule III prescription one time to a Louisiana-licensed pharmacy. A 30-day supply can be dispensed on that transfer. Because testosterone is Schedule III under the Louisiana Uniform Controlled Dangerous Substances Law, the original prescription cannot be telephoned or faxed between states in all circumstances; the receiving Louisiana pharmacist must confirm the originating state's pharmacist is willing and able to cancel the original on transfer.

For ongoing refills beyond that initial transfer, Louisiana law requires a valid prescriber-patient relationship with a Louisiana-licensed provider. This means establishing care with either an in-state in-person physician or a telehealth provider licensed in Louisiana. A 20-minute video visit with a telehealth TRT clinic accomplishes this and results in a new Louisiana prescription, typically sent electronically to the pharmacy of your choice on the same day.

Dosing, Application, and Monitoring After Starting AndroGel

Getting the prescription is the first step. Using it correctly determines whether it works.

AndroGel 1.62% is applied once each morning to clean, dry, intact skin on both upper arms and shoulders. The starting dose is 40.5 mg (two pump actuations). The FDA label allows titration to 20.25 mg (one actuation) if testosterone levels are above 1 to 050 ng/dL at steady state, or up to 81 mg (four actuations) if levels remain below 300 ng/dL after 14 or more days at the starting dose.

Absorption varies by application site. Applying to the abdomen, which was permitted with the older 1% formulation, is not recommended with the 1.62% product because the label data for the 1.62% version was established specifically for upper arm and shoulder application. Patients should wash hands thoroughly after application and avoid skin-to-skin contact with women or children for at least 2 hours, given the FDA's black-box warning regarding secondary testosterone exposure in pediatric patients.

Serum testosterone should be measured 2 to 8 hours after application (not immediately before the next dose) to capture the post-application peak. This timing is specified in the FDA prescribing information and matters: a trough measurement taken just before the next morning's dose will systematically underestimate the mean daily level and may trigger unnecessary dose increases.

Monitoring schedule per the Endocrine Society guideline (Bhasin et al. 2018):

• 3 to 6 months after initiation: testosterone level (drawn 2 to 8 hours post-application), hematocrit, PSA
• 12 months: repeat full panel including bone mineral density if baseline DEXA was obtained
• Annually thereafter: testosterone, hematocrit, PSA, symptom reassessment

A hematocrit above 54% requires dose reduction or temporary discontinuation. This is not rare: a meta-analysis of testosterone therapy trials found polycythemia occurred in approximately 5.8% of treated men versus 1.2% of controls (Xu et al., JCEM 2010, PMID 20173018).

What to Expect: Timeline from First Inquiry to First Dose

The following timeline applies to a Louisiana resident starting with no labs on file and using a telehealth platform.

Day 1: Complete online intake form and pay consultation fee (typically $75 to $150 for an initial telehealth visit, though some platforms bundle this into a monthly membership).

Days 1 to 3: Lab order sent to Labcorp or Quest. Patient visits nearest draw site. Louisiana has over 200 Labcorp and Quest patient service centers statewide, including locations in Houma, Alexandria, Monroe, and Lafayette.

Days 3 to 5: Lab results returned digitally to prescribing clinician. Video consult scheduled and completed. If testosterone is confirmed below 300 ng/dL on a single draw (with a second draw ordered or already on file), most telehealth clinicians will prescribe at this visit pending the second result, particularly when symptoms are consistent.

Days 5 to 7: Electronic prescription sent to chosen pharmacy or compounding pharmacy. Brand AndroGel at a retail pharmacy is typically dispensed same day. A compounded formulation shipped from a Louisiana 503A pharmacy generally arrives within 2 to 5 business days.

Weeks 6 to 8: First follow-up labs. Dose adjustment if needed.

Patients who already have qualifying labs (two morning testosterone values below 300 ng/dL drawn within the past 6 months) can compress this entire timeline to 24 to 48 hours.

Cost Breakdown for Louisiana Patients in 2025

Cost varies widely depending on insurance status, brand versus compounded choice, and telehealth platform.

| Route | Estimated Monthly Cost | |---|---| | Brand AndroGel 1.62%, cash pay (GoodRx) | $180 to $240 | | Brand AndroGel 1.62%, commercial insurance with PA approved | $10 to $60 copay | | Compounded testosterone gel 1.62%, 503A pharmacy | $40 to $90 | | Telehealth consult (initial, one-time) | $75 to $150 | | Required labs (without insurance) | $60 to $120 at reference lab |

Louisiana Medicaid (Healthy Louisiana) does not cover AndroGel for male hypogonadism. Men enrolled in Healthy Louisiana plans who need testosterone therapy must either pay cash, use a compounding pharmacy, or pursue a formulary exception, which requires documentation of medical necessity beyond a standard prior authorization request.